id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CDC-2022-0052-0003,CDC,CDC-2022-0052,Scientific Considerations for Potential Addition of Uterine Cancer to the List of Covered Conditions by the World Trade Center Health Program (Revised): Preliminary Assessment for the World Trade Center Health Program Scientific/Technical Advisory Committee,Supporting & Related Material,,2022-05-13T04:00:00Z,2022,5,,,2022-05-13T11:14:46Z,,0,0,0900006485077e61
CDC-2022-0052-0004,CDC,CDC-2022-0052,"Letter from Dr. Elizabeth Ward, Chair of the STAC, to the Administrator, regarding the STAC’s resolution on the addition of uterine cancer to the List of WTCHP Covered Conditions, received November 29, 2021",Supporting & Related Material,,2022-05-13T04:00:00Z,2022,5,,,2022-05-13T11:18:44Z,,0,0,0900006485077e62
CDC-2022-0052-0001,CDC,CDC-2022-0052,World Trade Center (WTC) Health Program; Addition of Uterine Cancer to the List of WTC-Related Health Conditions,Notice,,2022-05-10T04:00:00Z,2022,5,2022-05-10T04:00:00Z,2022-06-25T03:59:59Z,2022-06-26T01:00:18Z,2022-09708,0,0,090000648506592f